Indian Navy
Karnataka | Uttara Kannada |
- Download
Time left to bid
9
Days21
Hours59
MinutesTender Roadmap
Publish Date
06 May 2025
Tender is published for seller Participation.
Bid Submission End Date
27 May 2025
Last day to participate Tender on Gem platform.
Evaluation Date
27 May 2025
Technical committe will evaluate Bid and Open Results.
Earnest Amount | |||||||||||||||||||||||||||||
Refer Doc | |||||||||||||||||||||||||||||
Tender Amount | |||||||||||||||||||||||||||||
Refer Doc | |||||||||||||||||||||||||||||
Department | |||||||||||||||||||||||||||||
Department Of Military Affairs | |||||||||||||||||||||||||||||
Item Category | |||||||||||||||||||||||||||||
DORZOLAMIDE 2 PERCENTAGE TIMOLOL 0.5PERCENTAGE ED ED BRINZOLAMIDE 1.0 TIMOLOL 0.5 PERCENTAGE 5 ML ED BROMOFENAC ED CARBOXY METHYL CELLULOSE 0.5 PERCENTAGE BOTT OF 5 ML CMC ED ED CARBOXYMETHYL CELLULOSE 1 PERCENTAGE BOTTLE OF 5 ML ED CIPROFLOXACIN DEXAMETHASONE ED TIMOLOL MALETE 0.5 PERCENTAGE ED TRAVAPROST TIMOLOL LATANOPROST 0.005 PERCENTAGE EYE DROPS NEOMYCIN BECLOMETAHSONE CLOTRIMAZOLE ED EAR DROPS BRIMONIDINE 0.2 PERCENTAGE EYE DROPS CLOTRIMAZOLE 1 PERCENTAGE IP LIGNOCAINE 2 PERCENTAGE IP EAR DROP BOTT OF 10ML | |||||||||||||||||||||||||||||
Purchaser Address | |||||||||||||||||||||||||||||
UTTARA KANNADA | |||||||||||||||||||||||||||||
Work Description | |||||||||||||||||||||||||||||
752; DORZOLAMIDE 2 PERCENTAGE TIMOLOL 0.5PERCENTAGE ED ED BRINZOLAMIDE 1.0 TIMOLOL 0.5 PERCENTAGE 5 ML ED BROMOFENAC ED CARBOXY METHYL CELLULOSE 0.5 PERCENTAGE BOTT OF 5 ML CMC ED ED CARBOXYMETHYL CELLULOSE 1 PERCENTAGE BOTTLE OF 5 ML ED CIPROFLOXACIN DEXAMETHASONE ED TIMOLOL MALETE 0.5 PERCENTAGE ED TRAVAPROST TIMOLOL LATANOPROST 0.005 PERCENTAGE EYE DROPS NEOMYCIN BECLOMETAHSONE CLOTRIMAZOLE ED EAR DROPS BRIMONIDINE 0.2 PERCENTAGE EYE DROPS CLOTRIMAZOLE 1 PERCENTAGE IP LIGNOCAINE 2 PERCENTAGE IP EAR DROP BOTT OF 10ML
|
|||||||||||||||||||||||||||||
Eligibility | |||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||
My Evaluation Notes | |||||||||||||||||||||||||||||
|